Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b624510-f4d4-43f3-9b36-c1c027d58daa
Date 9/15/2016
Company Name HDL Therapeutics
Mailing Address 46701 Commerce Center Drive Plymouth, MI 48170 USA
Company Description We are a privately held cardiovascular device company and a leader in the field of reversing coronary atherosclerosis. Our innovative acute care therapeutic device called PDS-2™ System transforms a patient’s own plasma into an atherosclerostic reversal agent using our patented technology.
Proceeds Purposes Proceeds purposes were not disclosed. 13 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.